Stockreport

Roche's Alecensa latest beneficiary of faster China drug approvals [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche's Alecensa latest beneficiary of faster China drug approvals | Reuters Reuters Staff 1 Min Read ZURICH (Reuters) - Chinese regulators are speeding up drug approval [Read more]